Limiting State Flexibility in Drug Pricing

N Engl J Med. 2018 Sep 13;379(11):1002-1004. doi: 10.1056/NEJMp1809358.

Authors

Nicholas Bagley¹, Rachel E Sachs¹

Affiliation

¹ From the University of Michigan Law School, Ann Arbor (N.B.); and Washington University Law School, St. Louis (R.E.S.).

PMID: 30207910
DOI: 10.1056/NEJMp1809358

No abstract available

MeSH terms

Centers for Medicare and Medicaid Services, U.S.
Drug Approval / legislation & jurisprudence
Drug Costs
Drug Industry / legislation & jurisprudence*
Fees, Pharmaceutical / legislation & jurisprudence*
Formularies as Topic*
Government Regulation*
Insurance Coverage
Massachusetts
Medicaid / legislation & jurisprudence*
State Government*
United States
United States Food and Drug Administration